AU2001290146A1 - Compounds useful in the treatment of inflammatory diseases - Google Patents

Info

Publication number

AU2001290146A1

AU2001290146A1 AU2001290146A AU9014601A AU2001290146A1 AU 2001290146 A1 AU2001290146 A1 AU 2001290146A1 AU 2001290146 A AU2001290146 A AU 2001290146A AU 9014601 A AU9014601 A AU 9014601A AU 2001290146 A1 AU2001290146 A1 AU 2001290146A1

Authority

AU

Australia

Prior art keywords

formula

alkyl

compound

aryl

heteroaryl

Prior art date

2000-09-29

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001875 compounds Chemical class 0.000 title claims description 269
• 238000011282 treatment Methods 0.000 title claims description 15
• 208000027866 inflammatory disease Diseases 0.000 title claims description 9
• 125000000217 alkyl group Chemical group 0.000 claims description 125
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 76
• 229910052739 hydrogen Inorganic materials 0.000 claims description 72
• 239000001257 hydrogen Substances 0.000 claims description 66
• 229910052757 nitrogen Inorganic materials 0.000 claims description 53
• 238000000034 method Methods 0.000 claims description 36
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 35
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 34
• 125000003118 aryl group Chemical group 0.000 claims description 32
• 229910052760 oxygen Inorganic materials 0.000 claims description 30
• 150000003839 salts Chemical class 0.000 claims description 27
• 239000001301 oxygen Substances 0.000 claims description 26
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 25
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 25
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 22
• 239000005864 Sulphur Substances 0.000 claims description 22
• 125000001072 heteroaryl group Chemical group 0.000 claims description 21
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 21
• 239000012453 solvate Substances 0.000 claims description 21
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 20
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 20
• 208000006673 asthma Diseases 0.000 claims description 16
• 229910052736 halogen Inorganic materials 0.000 claims description 14
• 150000002367 halogens Chemical class 0.000 claims description 14
• 229920006395 saturated elastomer Polymers 0.000 claims description 14
• 125000003342 alkenyl group Chemical group 0.000 claims description 13
• 125000004433 nitrogen atom Chemical group N* 0.000 claims description 13
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 11
• 150000002431 hydrogen Chemical group 0.000 claims description 11
• 125000000392 cycloalkenyl group Chemical group 0.000 claims description 10
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 9
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 8
• 125000000304 alkynyl group Chemical group 0.000 claims description 8
• 239000003814 drug Substances 0.000 claims description 7
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 6
• 239000008194 pharmaceutical composition Substances 0.000 claims description 6
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 5
• 229910052799 carbon Inorganic materials 0.000 claims description 5
• 125000005843 halogen group Chemical group 0.000 claims description 5
• 125000005842 heteroatom Chemical group 0.000 claims description 5
• 238000004519 manufacturing process Methods 0.000 claims description 5
• 125000003831 tetrazolyl group Chemical group 0.000 claims description 5
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
• 239000005977 Ethylene Substances 0.000 claims description 4
• 150000001721 carbon Chemical group 0.000 claims description 4
• 125000002950 monocyclic group Chemical group 0.000 claims description 4
• 230000009467 reduction Effects 0.000 claims description 4
• 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
• GPLUUMAKBFSDIE-KRWDZBQOSA-N 4-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 GPLUUMAKBFSDIE-KRWDZBQOSA-N 0.000 claims description 2
• 239000000969 carrier Substances 0.000 claims description 2
• 239000003085 diluting agent Substances 0.000 claims description 2
• 150000002466 imines Chemical class 0.000 claims description 2
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
• 238000011321 prophylaxis Methods 0.000 claims description 2
• JZBGNRGEOVQVEE-LBPRGKRZSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methyltetrazol-5-yl)methyl]urea Chemical compound CN1N=NC(CNC(=O)NC[C@@H]2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 JZBGNRGEOVQVEE-LBPRGKRZSA-N 0.000 claims 1
• RLGDJANJVUKARK-SFHVURJKSA-N 4-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 RLGDJANJVUKARK-SFHVURJKSA-N 0.000 claims 1
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 315
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 216
• 239000000543 intermediate Substances 0.000 description 167
• 239000000203 mixture Substances 0.000 description 146
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 129
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 112
• 238000001819 mass spectrum Methods 0.000 description 106
• 239000000243 solution Substances 0.000 description 84
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 82
• -1 oxygen radicals Chemical class 0.000 description 65
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 58
• 239000002904 solvent Substances 0.000 description 58
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 48
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 42
• 239000007787 solid Substances 0.000 description 41
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 39
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 36
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 35
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 35
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 28
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 27
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
• 230000008569 process Effects 0.000 description 24
• 238000002414 normal-phase solid-phase extraction Methods 0.000 description 22
• 239000000741 silica gel Substances 0.000 description 22
• 229910002027 silica gel Inorganic materials 0.000 description 22
• 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 20
• 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 20
• BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 20
• 229920005989 resin Polymers 0.000 description 19
• 239000011347 resin Substances 0.000 description 19
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 18
• 238000002953 preparative HPLC Methods 0.000 description 18
• 238000003756 stirring Methods 0.000 description 18
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
• 229910021529 ammonia Inorganic materials 0.000 description 17
• 210000004027 cell Anatomy 0.000 description 17
• 210000003979 eosinophil Anatomy 0.000 description 17
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 17
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 16
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 16
• 235000011114 ammonium hydroxide Nutrition 0.000 description 16
• 201000010099 disease Diseases 0.000 description 16
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
• 239000003480 eluent Substances 0.000 description 16
• 238000004128 high performance liquid chromatography Methods 0.000 description 16
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 16
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
• 238000000746 purification Methods 0.000 description 15
• 238000005342 ion exchange Methods 0.000 description 14
• 239000003921 oil Substances 0.000 description 14
• 235000019198 oils Nutrition 0.000 description 14
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 13
• 239000000460 chlorine Substances 0.000 description 13
• 229910052801 chlorine Inorganic materials 0.000 description 13
• 239000000377 silicon dioxide Substances 0.000 description 13
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
• 235000019441 ethanol Nutrition 0.000 description 12
• 238000001704 evaporation Methods 0.000 description 12
• 230000008020 evaporation Effects 0.000 description 12
• 238000003818 flash chromatography Methods 0.000 description 12
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 11
• 102000019034 Chemokines Human genes 0.000 description 11
• 108010012236 Chemokines Proteins 0.000 description 11
• XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 10
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 10
• 229910000041 hydrogen chloride Inorganic materials 0.000 description 10
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 9
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 9
• 238000010828 elution Methods 0.000 description 9
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 9
• 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 9
• 125000001424 substituent group Chemical group 0.000 description 9
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 8
• KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 8
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
• 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 8
• 244000166102 Eucalyptus leucoxylon Species 0.000 description 8
• 239000004793 Polystyrene Substances 0.000 description 8
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
• 239000002585 base Substances 0.000 description 8
• 239000012267 brine Substances 0.000 description 8
• 239000004202 carbamide Substances 0.000 description 8
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 8
• 238000004587 chromatography analysis Methods 0.000 description 8
• 238000005516 engineering process Methods 0.000 description 8
• 238000001914 filtration Methods 0.000 description 8
• 235000019253 formic acid Nutrition 0.000 description 8
• 210000000265 leukocyte Anatomy 0.000 description 8
• 230000014759 maintenance of location Effects 0.000 description 8
• 239000012071 phase Substances 0.000 description 8
• 229920002223 polystyrene Polymers 0.000 description 8
• 125000006239 protecting group Chemical group 0.000 description 8
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
• 102100023688 Eotaxin Human genes 0.000 description 7
• 101710139422 Eotaxin Proteins 0.000 description 7
• 238000003556 assay Methods 0.000 description 7
• 239000012044 organic layer Substances 0.000 description 7
• 239000012074 organic phase Substances 0.000 description 7
• 229910000027 potassium carbonate Inorganic materials 0.000 description 7
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 239000002002 slurry Substances 0.000 description 7
• 238000000825 ultraviolet detection Methods 0.000 description 7
• HBAHZZVIEFRTEY-UHFFFAOYSA-N 2-heptylcyclohex-2-en-1-one Chemical compound CCCCCCCC1=CCCCC1=O HBAHZZVIEFRTEY-UHFFFAOYSA-N 0.000 description 6
• JKIHDSIADUBKPU-UHFFFAOYSA-N 4-(aminomethyl)benzamide Chemical compound NCC1=CC=C(C(N)=O)C=C1 JKIHDSIADUBKPU-UHFFFAOYSA-N 0.000 description 6
• 206010061218 Inflammation Diseases 0.000 description 6
• 108010058846 Ovalbumin Proteins 0.000 description 6
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
• 230000004913 activation Effects 0.000 description 6
• 239000005557 antagonist Substances 0.000 description 6
• HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 6
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
• 239000012043 crude product Substances 0.000 description 6
• 239000000706 filtrate Substances 0.000 description 6
• 230000004054 inflammatory process Effects 0.000 description 6
• 125000001624 naphthyl group Chemical group 0.000 description 6
• 229940092253 ovalbumin Drugs 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 238000010992 reflux Methods 0.000 description 6
• 235000017557 sodium bicarbonate Nutrition 0.000 description 6
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
• FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 238000002217 thermospray mass spectrum Methods 0.000 description 6
• 210000001519 tissue Anatomy 0.000 description 6
• NXLNNXIXOYSCMB-UHFFFAOYSA-N (4-nitrophenyl) carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(OC(Cl)=O)C=C1 NXLNNXIXOYSCMB-UHFFFAOYSA-N 0.000 description 5
• 102000009410 Chemokine receptor Human genes 0.000 description 5
• 108050000299 Chemokine receptor Proteins 0.000 description 5
• 241000725303 Human immunodeficiency virus Species 0.000 description 5
• 229920001367 Merrifield resin Polymers 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 210000003651 basophil Anatomy 0.000 description 5
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
• 125000002618 bicyclic heterocycle group Chemical group 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 230000001143 conditioned effect Effects 0.000 description 5
• 230000002757 inflammatory effect Effects 0.000 description 5
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 5
• 230000007115 recruitment Effects 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 206010039083 rhinitis Diseases 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• 229910052938 sodium sulfate Inorganic materials 0.000 description 5
• 239000003039 volatile agent Substances 0.000 description 5
• VIYIYSBQARQLCC-UHFFFAOYSA-N 2-[(3,4-dichlorophenyl)methylamino]ethanol Chemical compound OCCNCC1=CC=C(Cl)C(Cl)=C1 VIYIYSBQARQLCC-UHFFFAOYSA-N 0.000 description 4
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
• 239000005695 Ammonium acetate Substances 0.000 description 4
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
• 210000004241 Th2 cell Anatomy 0.000 description 4
• 235000019257 ammonium acetate Nutrition 0.000 description 4
• 229940043376 ammonium acetate Drugs 0.000 description 4
• 125000006615 aromatic heterocyclic group Chemical group 0.000 description 4
• 230000009286 beneficial effect Effects 0.000 description 4
• 230000035605 chemotaxis Effects 0.000 description 4
• 229960001270 d- tartaric acid Drugs 0.000 description 4
• 238000010511 deprotection reaction Methods 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 230000013764 eosinophil chemotaxis Effects 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 229910052731 fluorine Inorganic materials 0.000 description 4
• 239000011737 fluorine Substances 0.000 description 4
• 230000007062 hydrolysis Effects 0.000 description 4
• 238000006460 hydrolysis reaction Methods 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 230000004968 inflammatory condition Effects 0.000 description 4
• HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 4
• 125000004043 oxo group Chemical group O=* 0.000 description 4
• 125000003386 piperidinyl group Chemical group 0.000 description 4
• JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 4
• 210000002345 respiratory system Anatomy 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 229910000029 sodium carbonate Inorganic materials 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
• YZIFVWOCPGPNHB-UHFFFAOYSA-N 1,2-dichloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C(Cl)=C1 YZIFVWOCPGPNHB-UHFFFAOYSA-N 0.000 description 3
• HFKSPOZYFRZZBJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 HFKSPOZYFRZZBJ-UHFFFAOYSA-N 0.000 description 3
• ADAKRBAJFHTIEW-UHFFFAOYSA-N 1-chloro-4-isocyanatobenzene Chemical compound ClC1=CC=C(N=C=O)C=C1 ADAKRBAJFHTIEW-UHFFFAOYSA-N 0.000 description 3
• DUILGEYLVHGSEE-UHFFFAOYSA-N 2-(oxiran-2-ylmethyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1CO1 DUILGEYLVHGSEE-UHFFFAOYSA-N 0.000 description 3
• 206010066091 Bronchial Hyperreactivity Diseases 0.000 description 3
• 108010017316 CCR3 Receptors Proteins 0.000 description 3
• 241000700199 Cavia porcellus Species 0.000 description 3
• 206010014950 Eosinophilia Diseases 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 239000007832 Na2SO4 Substances 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
• 229960000583 acetic acid Drugs 0.000 description 3
• 125000003545 alkoxy group Chemical group 0.000 description 3
• 208000026935 allergic disease Diseases 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 230000003110 anti-inflammatory effect Effects 0.000 description 3
• 239000008346 aqueous phase Substances 0.000 description 3
• 208000010668 atopic eczema Diseases 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 230000036427 bronchial hyperreactivity Effects 0.000 description 3
• 125000002837 carbocyclic group Chemical group 0.000 description 3
• 238000004296 chiral HPLC Methods 0.000 description 3
• 229910052681 coesite Inorganic materials 0.000 description 3
• 239000006071 cream Substances 0.000 description 3
• 229910052906 cristobalite Inorganic materials 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 125000004188 dichlorophenyl group Chemical group 0.000 description 3
• CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 3
• 239000006260 foam Substances 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 239000011521 glass Substances 0.000 description 3
• 238000010438 heat treatment Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 125000002883 imidazolyl group Chemical group 0.000 description 3
• 239000012442 inert solvent Substances 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 125000000842 isoxazolyl group Chemical group 0.000 description 3
• FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical class OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 239000002932 luster Substances 0.000 description 3
• 235000019341 magnesium sulphate Nutrition 0.000 description 3
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
• 125000002757 morpholinyl group Chemical group 0.000 description 3
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
• 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 3
• 229920005990 polystyrene resin Polymers 0.000 description 3
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
• 238000006722 reduction reaction Methods 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 238000002821 scintillation proximity assay Methods 0.000 description 3
• 235000010356 sorbitol Nutrition 0.000 description 3
• 239000000600 sorbitol Substances 0.000 description 3
• 229910052682 stishovite Inorganic materials 0.000 description 3
• 239000001117 sulphuric acid Substances 0.000 description 3
• 235000011149 sulphuric acid Nutrition 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 125000000335 thiazolyl group Chemical group 0.000 description 3
• 125000001544 thienyl group Chemical group 0.000 description 3
• 229910052905 tridymite Inorganic materials 0.000 description 3
• MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
• 238000005160 1H NMR spectroscopy Methods 0.000 description 2
• HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
• HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
• LNEQRCLPPPXKGY-UHFFFAOYSA-N 4-(1-bromoethyl)-1,2-dichlorobenzene Chemical compound CC(Br)C1=CC=C(Cl)C(Cl)=C1 LNEQRCLPPPXKGY-UHFFFAOYSA-N 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 2
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 2
• 102000004499 CCR3 Receptors Human genes 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 241000700198 Cavia Species 0.000 description 2
• 108010055166 Chemokine CCL5 Proteins 0.000 description 2
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 241000701022 Cytomegalovirus Species 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• 201000004624 Dermatitis Diseases 0.000 description 2
• GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
• 206010048643 Hypereosinophilic syndrome Diseases 0.000 description 2
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
• 240000007472 Leucaena leucocephala Species 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 241000244206 Nematoda Species 0.000 description 2
• 208000030852 Parasitic disease Diseases 0.000 description 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
• 206010039094 Rhinitis perennial Diseases 0.000 description 2
• 208000036284 Rhinitis seasonal Diseases 0.000 description 2
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
• 229910006074 SO2NH2 Inorganic materials 0.000 description 2
• RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
• YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• UANWWXRZQGYWSR-SNVBAGLBSA-N [(2r)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methanamine Chemical compound C1CO[C@H](CN)CN1CC1=CC=C(Cl)C(Cl)=C1 UANWWXRZQGYWSR-SNVBAGLBSA-N 0.000 description 2
• UANWWXRZQGYWSR-JTQLQIEISA-N [(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methanamine Chemical compound C1CO[C@@H](CN)CN1CC1=CC=C(Cl)C(Cl)=C1 UANWWXRZQGYWSR-JTQLQIEISA-N 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
• 125000002947 alkylene group Chemical group 0.000 description 2
• 239000013566 allergen Substances 0.000 description 2
• 125000006242 amine protecting group Chemical group 0.000 description 2
• 230000003474 anti-emetic effect Effects 0.000 description 2
• 229940121363 anti-inflammatory agent Drugs 0.000 description 2
• 239000002260 anti-inflammatory agent Substances 0.000 description 2
• 239000002111 antiemetic agent Substances 0.000 description 2
• 229940125683 antiemetic agent Drugs 0.000 description 2
• 239000004599 antimicrobial Substances 0.000 description 2
• 201000008937 atopic dermatitis Diseases 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• 229910052794 bromium Inorganic materials 0.000 description 2
• 206010006451 bronchitis Diseases 0.000 description 2
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
• 239000003054 catalyst Substances 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
• 238000011049 filling Methods 0.000 description 2
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
• 230000006870 function Effects 0.000 description 2
• 125000002541 furyl group Chemical group 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 230000035874 hyperreactivity Effects 0.000 description 2
• 239000003018 immunosuppressive agent Substances 0.000 description 2
• 229940125721 immunosuppressive agent Drugs 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 125000001041 indolyl group Chemical group 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 2
• 230000000968 intestinal effect Effects 0.000 description 2
• 239000010410 layer Substances 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
• GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 2
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 239000002687 nonaqueous vehicle Substances 0.000 description 2
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
• 125000004193 piperazinyl group Chemical group 0.000 description 2
• 150000003053 piperidines Chemical class 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 235000018102 proteins Nutrition 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• 108090000623 proteins and genes Proteins 0.000 description 2
• 125000003373 pyrazinyl group Chemical group 0.000 description 2
• 125000004076 pyridyl group Chemical group 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000001932 seasonal effect Effects 0.000 description 2
• 235000009518 sodium iodide Nutrition 0.000 description 2
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
• 235000011152 sodium sulphate Nutrition 0.000 description 2
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
• 125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 125000005958 tetrahydrothienyl group Chemical group 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 125000001113 thiadiazolyl group Chemical group 0.000 description 2
• 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
• ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
• XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
• KDDNKZCVYQDGKE-UHFFFAOYSA-N (2-chlorophenyl)methanamine Chemical compound NCC1=CC=CC=C1Cl KDDNKZCVYQDGKE-UHFFFAOYSA-N 0.000 description 1
• QWWYJFASNBPMAX-UHFFFAOYSA-N (2-methyltetrazol-5-yl)methanamine;hydrochloride Chemical compound Cl.CN1N=NC(CN)=N1 QWWYJFASNBPMAX-UHFFFAOYSA-N 0.000 description 1
• VVRVZXIIKFLHIH-NRYLJRBGSA-N (2r)-2-aminopropan-1-ol Chemical compound C[C@@H](N)CO.C[C@@H](N)CO VVRVZXIIKFLHIH-NRYLJRBGSA-N 0.000 description 1
• BJFPYGGTDAYECS-UHFFFAOYSA-N (3-chlorophenyl)methanamine Chemical compound NCC1=CC=CC(Cl)=C1 BJFPYGGTDAYECS-UHFFFAOYSA-N 0.000 description 1
• YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
• STYCXUAGSTVHRS-MRXNPFEDSA-N (4-nitrophenyl) n-[[(2r)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)NC[C@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 STYCXUAGSTVHRS-MRXNPFEDSA-N 0.000 description 1
• STYCXUAGSTVHRS-INIZCTEOSA-N (4-nitrophenyl) n-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 STYCXUAGSTVHRS-INIZCTEOSA-N 0.000 description 1
• NVJYJLMFEGAWNO-NTISSMGPSA-N (4-nitrophenyl) n-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]carbamate;hydrochloride Chemical compound Cl.C1=CC([N+](=O)[O-])=CC=C1OC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 NVJYJLMFEGAWNO-NTISSMGPSA-N 0.000 description 1
• ZEJGXXDGEVFMKC-UHFFFAOYSA-N (4-nitrophenyl) n-prop-2-ynylcarbamate Chemical compound [O-][N+](=O)C1=CC=C(OC(=O)NCC#C)C=C1 ZEJGXXDGEVFMKC-UHFFFAOYSA-N 0.000 description 1
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
• DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
• MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
• ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
• LNZDTNYAFIUEPU-UHFFFAOYSA-N 1,4-oxazepan-2-ylmethanamine Chemical compound NCC1CNCCCO1 LNZDTNYAFIUEPU-UHFFFAOYSA-N 0.000 description 1
• WVCDSELVRXKGKD-UHFFFAOYSA-N 1-(1-benzoylpiperidin-4-yl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCN(CC2)C(=O)C=2C=CC=CC=2)OCC1 WVCDSELVRXKGKD-UHFFFAOYSA-N 0.000 description 1
• JXSPKRUNMHMICQ-UHFFFAOYSA-N 1-(2-bromoethoxy)-4-fluorobenzene Chemical compound FC1=CC=C(OCCBr)C=C1 JXSPKRUNMHMICQ-UHFFFAOYSA-N 0.000 description 1
• QZYUSYJXVMRQNM-UHFFFAOYSA-N 1-(3-bromophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=C(Br)C=CC=2)OCC1 QZYUSYJXVMRQNM-UHFFFAOYSA-N 0.000 description 1
• CETNYFPESALINJ-UHFFFAOYSA-N 1-(3-chlorophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound ClC1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 CETNYFPESALINJ-UHFFFAOYSA-N 0.000 description 1
• GEKMNZWPOKHNJK-UHFFFAOYSA-N 1-(3-cyanophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=C(C=CC=2)C#N)OCC1 GEKMNZWPOKHNJK-UHFFFAOYSA-N 0.000 description 1
• MKBLQSFKFNDVLX-UHFFFAOYSA-N 1-(4-bromophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(Br)=CC=2)OCC1 MKBLQSFKFNDVLX-UHFFFAOYSA-N 0.000 description 1
• IADADWNXRSNFRF-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(morpholin-2-ylmethyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCNC1 IADADWNXRSNFRF-UHFFFAOYSA-N 0.000 description 1
• CUEKMUYPOKHPEE-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(2-methoxyethyl)morpholin-2-yl]methyl]urea Chemical compound C1N(CCOC)CCOC1CNC(=O)NC1=CC=C(Cl)C=C1 CUEKMUYPOKHPEE-UHFFFAOYSA-N 0.000 description 1
• DNEKWVAUXSDQFQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(2-phenylsulfanylethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CCSC=2C=CC=CC=2)C1 DNEKWVAUXSDQFQ-UHFFFAOYSA-N 0.000 description 1
• MZOYOSRKYQNISE-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(3,4-dichlorobenzoyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(C(=O)C=2C=C(Cl)C(Cl)=CC=2)C1 MZOYOSRKYQNISE-UHFFFAOYSA-N 0.000 description 1
• GXCPRHGMOJUQCQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(cyanomethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC#N)C1 GXCPRHGMOJUQCQ-UHFFFAOYSA-N 0.000 description 1
• VOVMLQSVJMKLEN-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(naphthalen-2-ylmethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C3C=CC=CC3=CC=2)C1 VOVMLQSVJMKLEN-UHFFFAOYSA-N 0.000 description 1
• UWRSYIYMRLWCPN-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(3-chlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C=CC=2)C1 UWRSYIYMRLWCPN-UHFFFAOYSA-N 0.000 description 1
• ZEEVVNROOCMRQZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(3-iodophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(I)C=CC=2)C1 ZEEVVNROOCMRQZ-UHFFFAOYSA-N 0.000 description 1
• CIKUSCIEGFQUJK-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(4-ethenylphenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=CC(C=C)=CC=2)C1 CIKUSCIEGFQUJK-UHFFFAOYSA-N 0.000 description 1
• NSVOKHWMZIYXRT-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(5-chlorothiophen-2-yl)methyl]morpholin-2-yl]methyl]urea Chemical compound S1C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(Cl)=CC=2)OCC1 NSVOKHWMZIYXRT-UHFFFAOYSA-N 0.000 description 1
• MNTQHEQUOPXTHV-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[2-(4-fluorophenoxy)ethyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(F)=CC=C1OCCN1CC(CNC(=O)NC=2C=CC(Cl)=CC=2)OCC1 MNTQHEQUOPXTHV-UHFFFAOYSA-N 0.000 description 1
• WJXVPDSZLIYBBB-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[4-(4-chlorophenyl)-4-oxobutyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CCCC(=O)C=2C=CC(Cl)=CC=2)C1 WJXVPDSZLIYBBB-UHFFFAOYSA-N 0.000 description 1
• JSFRQVBURHCSRQ-UHFFFAOYSA-N 1-(4-cyanophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(=CC=2)C#N)OCC1 JSFRQVBURHCSRQ-UHFFFAOYSA-N 0.000 description 1
• NDZYPHLNJZSQJY-QNWVGRARSA-N 1-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-3-[(1r,2s)-2-[[(3s)-3-[(4-fluorophenyl)methyl]piperidin-1-yl]methyl]cyclohexyl]urea Chemical class CC1=C(C(=O)C)SC(NC(=O)N[C@H]2[C@@H](CCCC2)CN2C[C@H](CC=3C=CC(F)=CC=3)CCC2)=N1 NDZYPHLNJZSQJY-QNWVGRARSA-N 0.000 description 1
• LZIYAIRGDHSVED-UHFFFAOYSA-N 1-(bromomethyl)-3-chlorobenzene Chemical compound ClC1=CC=CC(CBr)=C1 LZIYAIRGDHSVED-UHFFFAOYSA-N 0.000 description 1
• BACZSVQZBSCWIG-UHFFFAOYSA-N 1-(bromomethyl)-3-iodobenzene Chemical compound BrCC1=CC=CC(I)=C1 BACZSVQZBSCWIG-UHFFFAOYSA-N 0.000 description 1
• ZRZHXNCATOYMJH-UHFFFAOYSA-N 1-(chloromethyl)-4-ethenylbenzene Chemical compound ClCC1=CC=C(C=C)C=C1 ZRZHXNCATOYMJH-UHFFFAOYSA-N 0.000 description 1
• HLQZCRVEEQKNMS-UHFFFAOYSA-N 1-(chloromethyl)-4-phenylbenzene Chemical group C1=CC(CCl)=CC=C1C1=CC=CC=C1 HLQZCRVEEQKNMS-UHFFFAOYSA-N 0.000 description 1
• XLUSNOUGZQJPRN-UHFFFAOYSA-N 1-(difluoromethoxy)-4-isocyanatobenzene Chemical compound FC(F)OC1=CC=C(N=C=O)C=C1 XLUSNOUGZQJPRN-UHFFFAOYSA-N 0.000 description 1
• VNHPWTGETWKSLP-UHFFFAOYSA-N 1-(isocyanatomethyl)-2-methylbenzene Chemical compound CC1=CC=CC=C1CN=C=O VNHPWTGETWKSLP-UHFFFAOYSA-N 0.000 description 1
• JCUQBSLBFAVVOS-UHFFFAOYSA-N 1-(isocyanatomethyl)-3-methylbenzene Chemical compound CC1=CC=CC(CN=C=O)=C1 JCUQBSLBFAVVOS-UHFFFAOYSA-N 0.000 description 1
• QRBHVARIMDDOOV-UHFFFAOYSA-N 1-(isocyanatomethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CN=C=O)C=C1 QRBHVARIMDDOOV-UHFFFAOYSA-N 0.000 description 1
• KNYDWDHLGFMGCO-UHFFFAOYSA-N 1-(isocyanatomethyl)-4-methylbenzene Chemical compound CC1=CC=C(CN=C=O)C=C1 KNYDWDHLGFMGCO-UHFFFAOYSA-N 0.000 description 1
• UPVROIATJVJTDN-UHFFFAOYSA-N 1-(morpholin-2-ylmethyl)-3-phenylurea Chemical compound C=1C=CC=CC=1NC(=O)NCC1CNCCO1 UPVROIATJVJTDN-UHFFFAOYSA-N 0.000 description 1
• ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
• KDWWACJTGVYXJA-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C(=CC=CC=2)Cl)OCC1 KDWWACJTGVYXJA-UHFFFAOYSA-N 0.000 description 1
• ORWBPAROFHCSAZ-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound ClC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 ORWBPAROFHCSAZ-UHFFFAOYSA-N 0.000 description 1
• XFOKYSOGMLELDG-UHFFFAOYSA-N 1-[(4-but-3-enylmorpholin-2-yl)methyl]-3-(4-chlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CCC=C)C1 XFOKYSOGMLELDG-UHFFFAOYSA-N 0.000 description 1
• SIGUZGFURPEAFO-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 SIGUZGFURPEAFO-UHFFFAOYSA-N 0.000 description 1
• ZMLBFPWNXWIJCP-CYBMUJFWSA-N 1-[[(2r)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@@H](CNC(=O)NCC#C)OCC1 ZMLBFPWNXWIJCP-CYBMUJFWSA-N 0.000 description 1
• LAHSCJWLPCJWQW-ZDUSSCGKSA-N 1-[[(2s)-4-[(2,3-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound ClC1=CC=CC(CN2C[C@H](CNC(=O)NCC#C)OCC2)=C1Cl LAHSCJWLPCJWQW-ZDUSSCGKSA-N 0.000 description 1
• FXOLBPVVGGAMSU-KRWDZBQOSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-pyrrolidin-1-ylsulfonylpropyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCCCS(=O)(=O)N2CCCC2)OCC1 FXOLBPVVGGAMSU-KRWDZBQOSA-N 0.000 description 1
• GTJVTUHFEGYPEV-SQKCAUCHSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(piperidin-4-ylmethyl)urea;dihydrochloride Chemical compound Cl.Cl.C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC2CCNCC2)OCC1 GTJVTUHFEGYPEV-SQKCAUCHSA-N 0.000 description 1
• DKUHRBJUMSGGJZ-AWEZNQCLSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[3-(methylsulfamoyl)propyl]urea Chemical compound C1CO[C@@H](CNC(=O)NCCCS(=O)(=O)NC)CN1CC1=CC=C(Cl)C(Cl)=C1 DKUHRBJUMSGGJZ-AWEZNQCLSA-N 0.000 description 1
• ZMLBFPWNXWIJCP-ZDUSSCGKSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC#C)OCC1 ZMLBFPWNXWIJCP-ZDUSSCGKSA-N 0.000 description 1
• RWZSUMWZLNZXGU-HNNXBMFYSA-N 1-[[(2s)-4-[(3-chlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound ClC1=CC=CC(CN2C[C@H](CNC(=O)NCC#C)OCC2)=C1 RWZSUMWZLNZXGU-HNNXBMFYSA-N 0.000 description 1
• IVDLZDAZTCGYPL-IBGZPJMESA-N 1-[[1-(cyclopropanecarbonyl)piperidin-4-yl]methyl]-3-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC2CCN(CC2)C(=O)C2CC2)OCC1 IVDLZDAZTCGYPL-IBGZPJMESA-N 0.000 description 1
• LFQKNPBHEVMIQQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2,6-dichloropyridin-4-yl)urea Chemical compound ClC1=NC(Cl)=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 LFQKNPBHEVMIQQ-UHFFFAOYSA-N 0.000 description 1
• DKGKGYIRSBFUAB-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-phenylethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCC=2C=CC=CC=2)OCC1 DKGKGYIRSBFUAB-UHFFFAOYSA-N 0.000 description 1
• UHYMDBFNUWROLZ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-fluorophenyl)urea Chemical compound FC1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 UHYMDBFNUWROLZ-UHFFFAOYSA-N 0.000 description 1
• OPYYDXYTYFFBBW-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-methylsulfanylphenyl)urea Chemical compound CSC1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 OPYYDXYTYFFBBW-UHFFFAOYSA-N 0.000 description 1
• DEMYSZUWDGRNGM-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 DEMYSZUWDGRNGM-UHFFFAOYSA-N 0.000 description 1
• WKOHCPXDTNECSH-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methylphenyl)methyl]urea Chemical compound CC1=CC=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 WKOHCPXDTNECSH-UHFFFAOYSA-N 0.000 description 1
• CRCIFIMKJNSOIV-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3-methylphenyl)methyl]urea Chemical compound CC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 CRCIFIMKJNSOIV-UHFFFAOYSA-N 0.000 description 1
• ICBCSZQUXHMHIO-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methoxyphenyl)methyl]urea Chemical compound C1=CC(OC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ICBCSZQUXHMHIO-UHFFFAOYSA-N 0.000 description 1
• FVSRFSLJDIVEQC-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methylphenyl)methyl]urea Chemical compound C1=CC(C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 FVSRFSLJDIVEQC-UHFFFAOYSA-N 0.000 description 1
• AMOYULQCQDEMTJ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]piperidin-4-yl]urea Chemical compound CC1=NOC(C)=C1S(=O)(=O)N1CCC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)CC1 AMOYULQCQDEMTJ-UHFFFAOYSA-N 0.000 description 1
• GXYOVBYXBLYSPG-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(difluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 GXYOVBYXBLYSPG-UHFFFAOYSA-N 0.000 description 1
• FLMNVALQNMHKEJ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(dimethylamino)phenyl]urea Chemical compound C1=CC(N(C)C)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 FLMNVALQNMHKEJ-UHFFFAOYSA-N 0.000 description 1
• XKRCHAWYLMZVQM-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 XKRCHAWYLMZVQM-UHFFFAOYSA-N 0.000 description 1
• XDVYKNRJEWXJIF-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(trifluoromethylsulfanyl)phenyl]urea Chemical compound C1=CC(SC(F)(F)F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 XDVYKNRJEWXJIF-UHFFFAOYSA-N 0.000 description 1
• QWWTVPBIPPUBKR-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-naphthalen-1-ylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C3=CC=CC=C3C=CC=2)OCC1 QWWTVPBIPPUBKR-UHFFFAOYSA-N 0.000 description 1
• GVHUJDWRRIGDCS-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-piperidin-4-ylurea;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCNCC2)OCC1 GVHUJDWRRIGDCS-UHFFFAOYSA-N 0.000 description 1
• ZMLBFPWNXWIJCP-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC#C)OCC1 ZMLBFPWNXWIJCP-UHFFFAOYSA-N 0.000 description 1
• YERNFDKVUFSFOB-UHFFFAOYSA-N 1-[[4-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]morpholin-2-yl]methyl]-3-phenylurea Chemical compound C1N(CC(=O)N2C3=CC=CC=C3CC2)CCOC1CNC(=O)NC1=CC=CC=C1 YERNFDKVUFSFOB-UHFFFAOYSA-N 0.000 description 1
• SJJRCWDWUXSGPZ-UHFFFAOYSA-N 1-benzyl-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=CC=CC=2)OCC1 SJJRCWDWUXSGPZ-UHFFFAOYSA-N 0.000 description 1
• YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 1
• VQVBCZQTXSHJGF-UHFFFAOYSA-N 1-bromo-3-isocyanatobenzene Chemical compound BrC1=CC=CC(N=C=O)=C1 VQVBCZQTXSHJGF-UHFFFAOYSA-N 0.000 description 1
• CZQIJQFTRGDODI-UHFFFAOYSA-N 1-bromo-4-isocyanatobenzene Chemical compound BrC1=CC=C(N=C=O)C=C1 CZQIJQFTRGDODI-UHFFFAOYSA-N 0.000 description 1
• HHIRBXHEYVDUAM-UHFFFAOYSA-N 1-chloro-3-isocyanatobenzene Chemical compound ClC1=CC=CC(N=C=O)=C1 HHIRBXHEYVDUAM-UHFFFAOYSA-N 0.000 description 1
• DEIWIHSUCRYIQL-UHFFFAOYSA-N 1-cyclohexyl-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCCCC2)OCC1 DEIWIHSUCRYIQL-UHFFFAOYSA-N 0.000 description 1
• RIKWVZGZRYDACA-UHFFFAOYSA-N 1-fluoro-3-isocyanatobenzene Chemical compound FC1=CC=CC(N=C=O)=C1 RIKWVZGZRYDACA-UHFFFAOYSA-N 0.000 description 1
• DSVGFKBFFICWLZ-UHFFFAOYSA-N 1-fluoro-4-isocyanatobenzene Chemical compound FC1=CC=C(N=C=O)C=C1 DSVGFKBFFICWLZ-UHFFFAOYSA-N 0.000 description 1
• SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical class C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 1
• SXJYSIBLFGQAND-UHFFFAOYSA-N 1-isocyanato-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(N=C=O)=C1 SXJYSIBLFGQAND-UHFFFAOYSA-N 0.000 description 1
• BKJABLMNBSVKCV-UHFFFAOYSA-N 1-isocyanato-3-methylsulfanylbenzene Chemical compound CSC1=CC=CC(N=C=O)=C1 BKJABLMNBSVKCV-UHFFFAOYSA-N 0.000 description 1
• LGPKFIGMLPDYEA-UHFFFAOYSA-N 1-isocyanato-4-(trifluoromethoxy)benzene Chemical compound FC(F)(F)OC1=CC=C(N=C=O)C=C1 LGPKFIGMLPDYEA-UHFFFAOYSA-N 0.000 description 1
• NYQSIHZNEJCZKX-UHFFFAOYSA-N 1-isocyanato-4-(trifluoromethylsulfanyl)benzene Chemical compound FC(F)(F)SC1=CC=C(N=C=O)C=C1 NYQSIHZNEJCZKX-UHFFFAOYSA-N 0.000 description 1
• PNBUGOFIKAHZRW-UHFFFAOYSA-N 1-isocyanato-4-phenoxybenzene Chemical compound C1=CC(N=C=O)=CC=C1OC1=CC=CC=C1 PNBUGOFIKAHZRW-UHFFFAOYSA-N 0.000 description 1
• WIRPZDICFIIBRF-UHFFFAOYSA-N 1-isocyanato-4-phenylbenzene Chemical group C1=CC(N=C=O)=CC=C1C1=CC=CC=C1 WIRPZDICFIIBRF-UHFFFAOYSA-N 0.000 description 1
• BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
• UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• PDNHLCRMUIGNBV-UHFFFAOYSA-N 1-pyridin-2-ylethanamine Chemical compound CC(N)C1=CC=CC=N1 PDNHLCRMUIGNBV-UHFFFAOYSA-N 0.000 description 1
• KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical compound C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 description 1
• OCDFIQXUCLQQHY-UHFFFAOYSA-N 2,6-dichloro-4-isocyanatopyridine Chemical compound ClC1=CC(N=C=O)=CC(Cl)=N1 OCDFIQXUCLQQHY-UHFFFAOYSA-N 0.000 description 1
• FUJSJWRORKKPAI-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetyl chloride Chemical compound ClC(=O)COC1=CC=C(Cl)C=C1Cl FUJSJWRORKKPAI-UHFFFAOYSA-N 0.000 description 1
• MSNOWIRBLULESE-UHFFFAOYSA-N 2-(3-pyrrolidin-1-ylsulfonylpropyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCS(=O)(=O)N1CCCC1 MSNOWIRBLULESE-UHFFFAOYSA-N 0.000 description 1
• RUHJZSZTSCSTCC-UHFFFAOYSA-N 2-(bromomethyl)naphthalene Chemical compound C1=CC=CC2=CC(CBr)=CC=C21 RUHJZSZTSCSTCC-UHFFFAOYSA-N 0.000 description 1
• HMIFIOONYFLDMW-UHFFFAOYSA-N 2-(oxiran-2-ylmethyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1CO1.O=C1C2=CC=CC=C2C(=O)N1CC1CO1 HMIFIOONYFLDMW-UHFFFAOYSA-N 0.000 description 1
• CKKBZPYNZHWHIL-UHFFFAOYSA-N 2-[2-[[(4-chlorophenyl)carbamoylamino]methyl]morpholin-4-yl]-2-phenylacetamide Chemical compound C=1C=CC=CC=1C(C(=O)N)N(C1)CCOC1CNC(=O)NC1=CC=C(Cl)C=C1 CKKBZPYNZHWHIL-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• GYQBANNDJUCMNR-UHFFFAOYSA-N 2-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]isoindole-1,3-dione Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CN2C(C3=CC=CC=C3C2=O)=O)OCC1 GYQBANNDJUCMNR-UHFFFAOYSA-N 0.000 description 1
• BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical compound CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 1
• AHAHDSZRVUVAGH-UHFFFAOYSA-N 2-bromo-2-phenylacetamide Chemical compound NC(=O)C(Br)C1=CC=CC=C1 AHAHDSZRVUVAGH-UHFFFAOYSA-N 0.000 description 1
• REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
• KNBBDZULQFKSIE-UHFFFAOYSA-N 2-bromoethyl benzoate Chemical compound BrCCOC(=O)C1=CC=CC=C1 KNBBDZULQFKSIE-UHFFFAOYSA-N 0.000 description 1
• 125000005999 2-bromoethyl group Chemical group 0.000 description 1
• ARHQTTKUMFDVJJ-UHFFFAOYSA-N 2-chloro-1-(2,3-dihydroindol-1-yl)ethanone Chemical compound C1=CC=C2N(C(=O)CCl)CCC2=C1 ARHQTTKUMFDVJJ-UHFFFAOYSA-N 0.000 description 1
• OYUNTGBISCIYPW-UHFFFAOYSA-N 2-chloroprop-2-enenitrile Chemical compound ClC(=C)C#N OYUNTGBISCIYPW-UHFFFAOYSA-N 0.000 description 1
• HACRKYQRZABURO-UHFFFAOYSA-N 2-phenylethyl isocyanate Chemical compound O=C=NCCC1=CC=CC=C1 HACRKYQRZABURO-UHFFFAOYSA-N 0.000 description 1
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• ZHCLIFKUVIFYBY-UHFFFAOYSA-N 2h-tetrazol-5-ylmethanamine Chemical compound NCC1=NN=NN1 ZHCLIFKUVIFYBY-UHFFFAOYSA-N 0.000 description 1
• VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
• RDXUBBUYWZAROQ-UHFFFAOYSA-N 3-(1,3-dioxoisoindol-2-yl)propane-1-sulfonyl chloride Chemical compound C1=CC=C2C(=O)N(CCCS(=O)(=O)Cl)C(=O)C2=C1 RDXUBBUYWZAROQ-UHFFFAOYSA-N 0.000 description 1
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
• RCZUDENHCBDSJA-UHFFFAOYSA-N 3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1-(4-fluorophenyl)-1-methylurea Chemical compound C=1C=C(F)C=CC=1N(C)C(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 RCZUDENHCBDSJA-UHFFFAOYSA-N 0.000 description 1
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
• SAXUNNOECOFBER-UHFFFAOYSA-N 3-ethylsulfonylpropan-1-amine;hydrochloride Chemical compound Cl.CCS(=O)(=O)CCCN SAXUNNOECOFBER-UHFFFAOYSA-N 0.000 description 1
• NZHPVPMRNASEQK-UHFFFAOYSA-N 3-isocyanatobenzonitrile Chemical compound O=C=NC1=CC=CC(C#N)=C1 NZHPVPMRNASEQK-UHFFFAOYSA-N 0.000 description 1
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
• OSDWCMNBYAUVMA-UHFFFAOYSA-N 3-pyrrolidin-1-ylsulfonylpropan-1-amine Chemical compound NCCCS(=O)(=O)N1CCCC1 OSDWCMNBYAUVMA-UHFFFAOYSA-N 0.000 description 1
• OAUSOTULBNOZKD-ZOWNYOTGSA-N 4-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]butanoic acid;hydrochloride Chemical compound Cl.C1CO[C@@H](CNC(=O)NCCCC(=O)O)CN1CC1=CC=C(Cl)C(Cl)=C1 OAUSOTULBNOZKD-ZOWNYOTGSA-N 0.000 description 1
• KEIBERUAXKRBSB-LMOVPXPDSA-N 4-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]benzamide;hydrochloride Chemical compound Cl.C1=CC(C(=O)N)=CC=C1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 KEIBERUAXKRBSB-LMOVPXPDSA-N 0.000 description 1
• UZZMPACVQXLUDR-UHFFFAOYSA-N 4-[[[4-[(3,4-dichlorophenyl)methyl]-1,4-oxazepan-2-yl]methylcarbamoylamino]methyl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1CNC(=O)NCC1OCCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 UZZMPACVQXLUDR-UHFFFAOYSA-N 0.000 description 1
• DMAYBPBPEUFIHJ-UHFFFAOYSA-N 4-bromobut-1-ene Chemical compound BrCCC=C DMAYBPBPEUFIHJ-UHFFFAOYSA-N 0.000 description 1
• UKCHLVFIVJBCKE-UHFFFAOYSA-N 4-chloro-1-(4-chlorophenyl)butan-1-one Chemical compound ClCCCC(=O)C1=CC=C(Cl)C=C1 UKCHLVFIVJBCKE-UHFFFAOYSA-N 0.000 description 1
• VLWRKVBQUANIGI-UHFFFAOYSA-N 4-fluoro-n-methylaniline Chemical compound CNC1=CC=C(F)C=C1 VLWRKVBQUANIGI-UHFFFAOYSA-N 0.000 description 1
• 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
• YZEHDFBYSOKBED-UHFFFAOYSA-N 4-isocyanato-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(N=C=O)C=C1 YZEHDFBYSOKBED-UHFFFAOYSA-N 0.000 description 1
• TVSXDZNUTPLDKY-UHFFFAOYSA-N 4-isocyanatobenzonitrile Chemical compound O=C=NC1=CC=C(C#N)C=C1 TVSXDZNUTPLDKY-UHFFFAOYSA-N 0.000 description 1
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
• 235000019489 Almond oil Nutrition 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 241001147657 Ancylostoma Species 0.000 description 1
• 241001465677 Ancylostomatoidea Species 0.000 description 1
• 241000244186 Ascaris Species 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 208000009079 Bronchial Spasm Diseases 0.000 description 1
• 208000014181 Bronchial disease Diseases 0.000 description 1
• 206010006458 Bronchitis chronic Diseases 0.000 description 1
• 206010006482 Bronchospasm Diseases 0.000 description 1
• 241000244036 Brugia Species 0.000 description 1
• VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
• 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 1
• 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 1
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
• 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 102000001902 CC Chemokines Human genes 0.000 description 1
• 108010040471 CC Chemokines Proteins 0.000 description 1
• 102000018201 CC chemokine receptor 3 Human genes 0.000 description 1
• 108091008927 CC chemokine receptors Proteins 0.000 description 1
• 102000005674 CCR Receptors Human genes 0.000 description 1
• 108010059108 CD18 Antigens Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 208000026368 Cestode infections Diseases 0.000 description 1
• 108010083647 Chemokine CCL24 Proteins 0.000 description 1
• 229940122444 Chemokine receptor antagonist Drugs 0.000 description 1
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 206010010741 Conjunctivitis Diseases 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 206010012434 Dermatitis allergic Diseases 0.000 description 1
• 206010012438 Dermatitis atopic Diseases 0.000 description 1
• 206010051392 Diapedesis Diseases 0.000 description 1
• 239000004150 EU approved colour Substances 0.000 description 1
• 206010014096 Echinococciasis Diseases 0.000 description 1
• 208000009366 Echinococcosis Diseases 0.000 description 1
• 241000244160 Echinococcus Species 0.000 description 1
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 206010016675 Filariasis lymphatic Diseases 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 208000006968 Helminthiasis Diseases 0.000 description 1
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
• 208000037263 Lymphatic filariasis Diseases 0.000 description 1
• 235000019759 Maize starch Nutrition 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 241000907681 Morpho Species 0.000 description 1
• 229920000715 Mucilage Polymers 0.000 description 1
• ZKVHOGWVRKQVHP-UHFFFAOYSA-N N,N-diethylethanamine (4-nitrophenyl) N-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]carbamate Chemical compound C(C)N(CC)CC.ClC=1C=C(CN2CC(OCC2)CNC(OC2=CC=C(C=C2)[N+](=O)[O-])=O)C=CC1Cl ZKVHOGWVRKQVHP-UHFFFAOYSA-N 0.000 description 1
• 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
• 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
• 241000243981 Onchocerca Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000018262 Peripheral vascular disease Diseases 0.000 description 1
• 108700020962 Peroxidase Proteins 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 description 1
• 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 208000003251 Pruritus Diseases 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 206010039085 Rhinitis allergic Diseases 0.000 description 1
• MMINPRFOTQXLFZ-UHFFFAOYSA-N S1CCOCC1.ClC=1C=C(CN2CC(OCC2)CNC(=O)N2CCSCC2)C=CC1Cl Chemical compound S1CCOCC1.ClC=1C=C(CN2CC(OCC2)CNC(=O)N2CCSCC2)C=CC1Cl MMINPRFOTQXLFZ-UHFFFAOYSA-N 0.000 description 1
• 241001442514 Schistosomatidae Species 0.000 description 1
• GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• 239000004141 Sodium laurylsulphate Substances 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 241000244174 Strongyloides Species 0.000 description 1
• OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
• 241000244155 Taenia Species 0.000 description 1
• 208000009205 Tinnitus Diseases 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 241000243774 Trichinella Species 0.000 description 1
• 102000001400 Tryptase Human genes 0.000 description 1
• 108060005989 Tryptase Proteins 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 108010046516 Wheat Germ Agglutinins Proteins 0.000 description 1
• 241000244005 Wuchereria bancrofti Species 0.000 description 1
• BNSWJGPOZUPHLN-UMJHXOGRSA-N [(2S)-4-[1-(3,4-dichlorophenyl)ethyl]morpholin-2-yl]methylcarbamic acid Chemical compound C=1C=C(Cl)C(Cl)=CC=1C(C)N1CCO[C@@H](CNC(O)=O)C1 BNSWJGPOZUPHLN-UMJHXOGRSA-N 0.000 description 1
• CIWLFBGMCUZVPO-JTQLQIEISA-N [(2s)-4-[(2,3-dichlorophenyl)methyl]morpholin-2-yl]methanamine Chemical compound C1CO[C@@H](CN)CN1CC1=CC=CC(Cl)=C1Cl CIWLFBGMCUZVPO-JTQLQIEISA-N 0.000 description 1
• MSRSSSIIOKVGIL-LBPRGKRZSA-N [(2s)-4-[(3-chlorophenyl)methyl]morpholin-2-yl]methanamine Chemical compound C1CO[C@@H](CN)CN1CC1=CC=CC(Cl)=C1 MSRSSSIIOKVGIL-LBPRGKRZSA-N 0.000 description 1
• HNEWQPPOKGJEOY-QMMMGPOBSA-N [(2s)-4-[(5-chlorothiophen-2-yl)methyl]morpholin-2-yl]methanamine Chemical compound C1CO[C@@H](CN)CN1CC1=CC=C(Cl)S1 HNEWQPPOKGJEOY-QMMMGPOBSA-N 0.000 description 1
• UANWWXRZQGYWSR-UHFFFAOYSA-N [4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methanamine Chemical class C1COC(CN)CN1CC1=CC=C(Cl)C(Cl)=C1 UANWWXRZQGYWSR-UHFFFAOYSA-N 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 239000012445 acidic reagent Substances 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 239000000464 adrenergic agent Substances 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
• 125000002723 alicyclic group Chemical group 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 201000010105 allergic rhinitis Diseases 0.000 description 1
• HXBPYFMVGFDZFT-UHFFFAOYSA-N allyl isocyanate Chemical compound C=CCN=C=O HXBPYFMVGFDZFT-UHFFFAOYSA-N 0.000 description 1
• 239000008168 almond oil Substances 0.000 description 1
• CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
• 238000010976 amide bond formation reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
• VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
• 230000002052 anaphylactic effect Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000001387 anti-histamine Effects 0.000 description 1
• 238000011861 anti-inflammatory therapy Methods 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 229940053202 antiepileptics carboxamide derivative Drugs 0.000 description 1
• 229940125715 antihistaminic agent Drugs 0.000 description 1
• 239000000739 antihistaminic agent Substances 0.000 description 1
• 229960005475 antiinfective agent Drugs 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 239000003443 antiviral agent Substances 0.000 description 1
• 229940121357 antivirals Drugs 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 125000003710 aryl alkyl group Chemical group 0.000 description 1
• METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 229950000210 beclometasone dipropionate Drugs 0.000 description 1
• PUDYSBKPGVXBNQ-UHFFFAOYSA-N benzamide;morpholine Chemical class C1COCCN1.NC(=O)C1=CC=CC=C1 PUDYSBKPGVXBNQ-UHFFFAOYSA-N 0.000 description 1
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 1
• PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
• JLHGVBVBEFSEEY-UHFFFAOYSA-N benzyl 2-(aminomethyl)morpholine-4-carboxylate Chemical compound C1COC(CN)CN1C(=O)OCC1=CC=CC=C1 JLHGVBVBEFSEEY-UHFFFAOYSA-N 0.000 description 1
• DWFOTMSOPRILKN-UHFFFAOYSA-N benzyl 2-[[(2,2,2-trifluoroacetyl)amino]methyl]morpholine-4-carboxylate Chemical compound C1COC(CNC(=O)C(F)(F)F)CN1C(=O)OCC1=CC=CC=C1 DWFOTMSOPRILKN-UHFFFAOYSA-N 0.000 description 1
• HMHOQMOCSGGNGB-UHFFFAOYSA-N benzyl 2-[[(4-chlorophenyl)carbamoylamino]methyl]morpholine-4-carboxylate Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(C(=O)OCC=2C=CC=CC=2)C1 HMHOQMOCSGGNGB-UHFFFAOYSA-N 0.000 description 1
• HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
• 125000002527 bicyclic carbocyclic group Chemical group 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 239000012148 binding buffer Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 229910000085 borane Inorganic materials 0.000 description 1
• 229960004436 budesonide Drugs 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000000337 buffer salt Substances 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 235000010980 cellulose Nutrition 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 239000002559 chemokine receptor antagonist Substances 0.000 description 1
• 239000005482 chemotactic factor Substances 0.000 description 1
• 208000007451 chronic bronchitis Diseases 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 208000037976 chronic inflammation Diseases 0.000 description 1
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
• 201000009151 chronic rhinitis Diseases 0.000 description 1
• 150000001860 citric acid derivatives Chemical class 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 229960001334 corticosteroids Drugs 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 229960000265 cromoglicic acid Drugs 0.000 description 1
• 229960001681 croscarmellose sodium Drugs 0.000 description 1
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
• 239000012045 crude solution Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 125000004093 cyano group Chemical group *C#N 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
• ZOOSILUVXHVRJE-UHFFFAOYSA-N cyclopropanecarbonyl chloride Chemical compound ClC(=O)C1CC1 ZOOSILUVXHVRJE-UHFFFAOYSA-N 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 239000000824 cytostatic agent Substances 0.000 description 1
• 230000001085 cytostatic effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
• 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 206010013663 drug dependence Diseases 0.000 description 1
• 239000008157 edible vegetable oil Substances 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000003602 elastase inhibitor Substances 0.000 description 1
• 238000000132 electrospray ionisation Methods 0.000 description 1
• 208000006036 elephantiasis Diseases 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 210000003038 endothelium Anatomy 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 238000010931 ester hydrolysis Methods 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
• 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
• MPLGEOONJGVDJH-UHFFFAOYSA-N ethyl 2-[2-[[(4-chlorophenyl)carbamoylamino]methyl]morpholin-4-yl]-2-phenylacetate Chemical compound C=1C=CC=CC=1C(C(=O)OCC)N(C1)CCOC1CNC(=O)NC1=CC=C(Cl)C=C1 MPLGEOONJGVDJH-UHFFFAOYSA-N 0.000 description 1
• BKTKLDMYHTUESO-UHFFFAOYSA-N ethyl 2-bromo-2-phenylacetate Chemical compound CCOC(=O)C(Br)C1=CC=CC=C1 BKTKLDMYHTUESO-UHFFFAOYSA-N 0.000 description 1
• IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 235000019197 fats Nutrition 0.000 description 1
• 229960001022 fenoterol Drugs 0.000 description 1
• RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
• 208000005239 filarial elephantiasis Diseases 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000013312 flour Nutrition 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 125000001207 fluorophenyl group Chemical group 0.000 description 1
• 229960000289 fluticasone propionate Drugs 0.000 description 1
• WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 150000004675 formic acid derivatives Chemical class 0.000 description 1
• 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
• BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
• 229960002848 formoterol Drugs 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
• 230000009454 functional inhibition Effects 0.000 description 1
• 230000007661 gastrointestinal function Effects 0.000 description 1
• 230000005176 gastrointestinal motility Effects 0.000 description 1
• 230000002640 gastrokinetic effect Effects 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000001727 glucose Nutrition 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 125000006277 halobenzyl group Chemical group 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 238000007327 hydrogenolysis reaction Methods 0.000 description 1
• 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
• 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
• 208000024364 idiopathic hypereosinophilic syndrome Diseases 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 208000002551 irritable bowel syndrome Diseases 0.000 description 1
• YDNLNVZZTACNJX-UHFFFAOYSA-N isocyanatomethylbenzene Chemical compound O=C=NCC1=CC=CC=C1 YDNLNVZZTACNJX-UHFFFAOYSA-N 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 150000003893 lactate salts Chemical class 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 230000023404 leukocyte cell-cell adhesion Effects 0.000 description 1
• 239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 125000005647 linker group Chemical group 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
• 229960003088 loratadine Drugs 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 150000002688 maleic acid derivatives Chemical class 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 229960000582 mepyramine Drugs 0.000 description 1
• YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 239000002032 methanolic fraction Substances 0.000 description 1
• 229960001869 methapyrilene Drugs 0.000 description 1
• HNJJXZKZRAWDPF-UHFFFAOYSA-N methapyrilene Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CS1 HNJJXZKZRAWDPF-UHFFFAOYSA-N 0.000 description 1
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
• XWEPQLDXAMNWJQ-UHFFFAOYSA-N methyl 3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]benzoate Chemical compound COC(=O)C1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 XWEPQLDXAMNWJQ-UHFFFAOYSA-N 0.000 description 1
• WBGWGERFPSYHDT-UHFFFAOYSA-N methyl 3-isocyanatobenzoate Chemical compound COC(=O)C1=CC=CC(N=C=O)=C1 WBGWGERFPSYHDT-UHFFFAOYSA-N 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
• 229960002744 mometasone furoate Drugs 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 150000004682 monohydrates Chemical class 0.000 description 1
• BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
• OXYALYJRWGRVAM-UHFFFAOYSA-N morpholin-2-ylmethanamine Chemical compound NCC1CNCCO1 OXYALYJRWGRVAM-UHFFFAOYSA-N 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• YNTOKMNHRPSGFU-UHFFFAOYSA-N n-Propyl carbamate Chemical compound CCCOC(N)=O YNTOKMNHRPSGFU-UHFFFAOYSA-N 0.000 description 1
• JLFWORHZSACMOG-UHFFFAOYSA-N n-[3-(aminomethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(CN)=C1 JLFWORHZSACMOG-UHFFFAOYSA-N 0.000 description 1
• LFHXYZFGXFIMCN-UHFFFAOYSA-N n-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)N2CCS(=O)(=O)CC2)OCC1 LFHXYZFGXFIMCN-UHFFFAOYSA-N 0.000 description 1
• QMJAUNLNEXWRJI-UHFFFAOYSA-N n-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-2,2,2-trifluoroacetamide Chemical compound C1COC(CNC(=O)C(F)(F)F)CN1CC1=CC=C(Cl)C(Cl)=C1 QMJAUNLNEXWRJI-UHFFFAOYSA-N 0.000 description 1
• 229960002259 nedocromil sodium Drugs 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 239000012299 nitrogen atmosphere Substances 0.000 description 1
• 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
• 238000010899 nucleation Methods 0.000 description 1
• 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 125000001715 oxadiazolyl group Chemical group 0.000 description 1
• 125000002971 oxazolyl group Chemical group 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 230000008855 peristalsis Effects 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 238000005191 phase separation Methods 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 235000021317 phosphate Nutrition 0.000 description 1
• 239000002587 phosphodiesterase IV inhibitor Substances 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 208000015768 polyposis Diseases 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 239000004810 polytetrafluoroethylene Substances 0.000 description 1
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 239000012286 potassium permanganate Substances 0.000 description 1
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 229940116317 potato starch Drugs 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• 125000003226 pyrazolyl group Chemical group 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 150000003235 pyrrolidines Chemical class 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 238000006268 reductive amination reaction Methods 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• 239000011369 resultant mixture Substances 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 229960002052 salbutamol Drugs 0.000 description 1
• 229960004017 salmeterol Drugs 0.000 description 1
• 230000002000 scavenging effect Effects 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 235000020374 simple syrup Nutrition 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 229940080313 sodium starch Drugs 0.000 description 1
• 235000010265 sodium sulphite Nutrition 0.000 description 1
• 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000000935 solvent evaporation Methods 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 239000001593 sorbitan monooleate Substances 0.000 description 1
• 235000011069 sorbitan monooleate Nutrition 0.000 description 1
• 229940035049 sorbitan monooleate Drugs 0.000 description 1
• 235000015096 spirit Nutrition 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 229940032147 starch Drugs 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 208000011117 substance-related disease Diseases 0.000 description 1
• 150000003890 succinate salts Chemical class 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 150000003892 tartrate salts Chemical class 0.000 description 1
• 229960000195 terbutaline Drugs 0.000 description 1
• MTMBHUYOIZWQAJ-UHFFFAOYSA-N tert-butyl 2-(aminomethyl)morpholine-4-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCOC(CN)C1 MTMBHUYOIZWQAJ-UHFFFAOYSA-N 0.000 description 1
• IYJOSZOYXFEWBJ-INIZCTEOSA-N tert-butyl 4-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]butanoate Chemical compound C1CO[C@@H](CNC(=O)NCCCC(=O)OC(C)(C)C)CN1CC1=CC=C(Cl)C(Cl)=C1 IYJOSZOYXFEWBJ-INIZCTEOSA-N 0.000 description 1
• FJJLPTZIIDKKTH-UHFFFAOYSA-N tert-butyl 4-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 FJJLPTZIIDKKTH-UHFFFAOYSA-N 0.000 description 1
• GAUIAHCWFZBNNE-IBGZPJMESA-N tert-butyl 4-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 GAUIAHCWFZBNNE-IBGZPJMESA-N 0.000 description 1
• CZVNLCOJFFYZPG-UHFFFAOYSA-N tert-butyl 4-aminobutanoate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)CCCN CZVNLCOJFFYZPG-UHFFFAOYSA-N 0.000 description 1
• YZFOPEDXXMVAMD-UHFFFAOYSA-N tert-butyl n-(2h-tetrazol-5-ylmethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC=1N=NNN=1 YZFOPEDXXMVAMD-UHFFFAOYSA-N 0.000 description 1
• IOKGWQZQCNXXLD-UHFFFAOYSA-N tert-butyl n-(3-bromopropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCBr IOKGWQZQCNXXLD-UHFFFAOYSA-N 0.000 description 1
• IGBBRNJOFMZPNQ-UHFFFAOYSA-N tert-butyl n-(3-ethylsulfonylpropyl)carbamate Chemical compound CCS(=O)(=O)CCCNC(=O)OC(C)(C)C IGBBRNJOFMZPNQ-UHFFFAOYSA-N 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 229930192474 thiophene Natural products 0.000 description 1
• RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
• 231100000886 tinnitus Toxicity 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 208000037816 tissue injury Diseases 0.000 description 1
• 230000017423 tissue regeneration Effects 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 229960002117 triamcinolone acetonide Drugs 0.000 description 1
• YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• 239000002750 tryptase inhibitor Substances 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 238000003828 vacuum filtration Methods 0.000 description 1
• 230000007502 viral entry Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1